- Fund Type: Open-End Fund
- Objective: Country Fund-Switzerland
- Asset Class: Equity
- Geographic Focus: Switzerland
Snapshot for DWS Aktien Schweiz (D2W8)
| Open: | - | High - Low: | - | Primary Exchange: | Tradegate |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | 34.6700 - 37.0100 | Beta vs SPI: | - |
Fund Profile & Information for D2W8
DWS Aktien Schweiz is an open-end investment fund incorporated in Germany. The Fund's objective is to maximize capital appreciation. The Fund invests at least two thirds of its assets in Swiss equities.
| Inception Date: | Telephone: | 49-1803-10111011 Tel | |
|---|---|---|---|
| Managers: | UDO ROSENDAHL | ||
| Web Site: | www.dws.de | ||
Fundamentals for D2W8
| NAV | (on 2013-01-15) 42.2300 |
|---|---|
| Assets (M) | (on 2013-05-17) 360.6920 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | - |
| Average 52-Week % Premium | - |
| Fund Leveraged | N |
Dividends for D2W8
No dividends reported
Performance for D2W8
| 1-Month | - | 1-Year | - |
|---|---|---|---|
| 3-Month | - | 3-Year | - |
| Year To Date | - | 5-Year | - |
| Expense Ratio | - |
Top Fund Holdings for D2W8
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Nestle SA | 550,000 | 37,702,500 | 9.782% |
| Novartis AG | 550,000 | 36,960,000 | 9.590% |
| Syngenta AG | 86,000 | 34,210,800 | 8.876% |
| Roche Holding AG | 85,000 | 18,785,000 | 4.874% |
| UBS AG | 1,260,000 | 18,509,400 | 4.803% |
| ABB Ltd | 845,000 | 18,201,300 | 4.723% |
| Roche Holding AG | 80,000 | 17,616,000 | 4.571% |
| Cie Financiere Richemont SA | 235,000 | 17,484,000 | 4.536% |
| Burckhardt Compression Holding | 47,000 | 16,356,000 | 4.244% |
| Schindler Holding AG | 110,000 | 15,279,000 | 3.964% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page